Zhejiang Garden Biopharmaceutical (300401.SZ) has obtained the registration certificate for Duosu caffeine tablets.

Zhejiang Garden Biopharmaceutical (300401.SZ) announced that its wholly-owned subsidiary Zhejiang Huayuan Pharmaceutical Co., Ltd. (referred to as "Huayuan Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for its product "Doxophylline Tablets," which is considered equivalent to passing the generic drug quality and efficacy consistency evaluation. Doxophylline Tablets are mainly used for bronchial asthma, chronic bronchitis with wheezing, and other breathing difficulties caused by bronchospasms.